Knowledge and perceptions about nicotine, nicotine replacement therapies and electronic cigarettes among healthcare professionals in Greece

International Journal of Environmental Research and Public Health

Volumn 13, Issue 5, 2016, Pages

  Moysidou, Anastasia ^a   Farsalinos, Konstantinos E ^b   Voudris, Vassilis ^b   Merakou, Kyriakoula ^a   Kourea, Kallirrhoe ^a   Barbouni, Anastasia ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Electronic cigarettes; Healthcare; Nicotine; Nurses; Physicians; Smoking harm reduction

Indexed keywords

NICOTINE;

HEALTH CARE; HEALTH IMPACT; HEALTH WORKER; KNOWLEDGE; PERCEPTION; SMOKING;

ADULT; ARTICLE; CARDIOLOGIST; CONTROLLED STUDY; E-MAIL; ELECTRONIC CIGARETTE; FEMALE; GREECE; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; MALE; NICOTINE REPLACEMENT THERAPY; NURSE; ONLINE SYSTEM; PHYSICIAN; PROFESSIONAL KNOWLEDGE; PULMONOLOGIST; SMOKING; SMOKING CESSATION; WORK ENVIRONMENT; ADVERSE EFFECTS; ATTITUDE TO HEALTH; HEALTH CARE PERSONNEL; PERCEPTION; PROCEDURES; QUESTIONNAIRE; TOBACCO USE DISORDER;

ATHENS [ATTICA]; ATTICA; GREECE;

NICOTIANA TABACUM;

ADULT; ELECTRONIC CIGARETTES; FEMALE; GREECE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MALE; NICOTINE; PERCEPTION; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TOBACCO USE DISORDER;

EID: 84969579926     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13050514     Document Type: Article

References (78)

1. World Health Organization. The European Tobacco Control Report 2007. Available online: http://www.euro.who.int/data/assets/pdf_file/0005/68117/E89842.pdf (accessed on 13 September 2015).
2. European Commission. Eurobarometer 429. Attitudes of Europeans towards Tobacco and Electronic Cigarettes, 2014. Available online: http://ec.europa.eu/public_opinion/archives/ebs/ebs_429_en.pdf (accessed on 13 September 2015).
3. Moore, D.; Aveyard, P.; Connock, M.; Wang, D.; Fry-Smith, A.; Barton, P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ 2009, 338, b1024. [CrossRef] [PubMed]
4. Kotz, D.; Brown, J.; West, R. “Real-world” effectiveness of smoking cessation treatments: A population study. Addiction 2014, 109, 491–499. [CrossRef] [PubMed]
5. Sweeney, C.T.; Fant, R.V.; Fagerstrom, K.O.; McGovern, J.F.; Henningfield, J.E. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 2001, 15, 453–467. [CrossRef] [PubMed]
6. Rigotti, N.A.; Pipe, A.L.; Benowitz, N.L.; Arteaga, C.; Garza, D.; Tonstad, S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circulation 2009, 121, 221–229. [CrossRef] [PubMed]
7. Casella, G.; Caponnetto, P.; Polosa, R. Therapeutic advances in the treatment of nicotine addiction: Present and future. Ther. Adv. Chronic Dis. 2010, 1, 95–106. [CrossRef] [PubMed]
8. European Commission. Special Eurobarometer 385. Attitudes of Europeans towards Tobacco and Electronic Cigarettes, May 2012. Available online: http://ec.europa.eu/health/tobacco/docs/eurobaro_attitudes_towards_tobacco_2012_en.pdf (accessed on 10 December 2015).
9. Royal College of Physicians. Ending Tobacco Smoking in Britain. Radical Strategies for Prevention and Harm Reduction in Nicotine Addiction; Royal College of Physicians: London, UK, 2008; Available online: http: //www.rcplondon.ac.uk/publications/ending-tobacco-smoking-britain (accessed on 2 December 2015).
10. WHO-IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Available online: http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf (accessed on 5 December 2015).
11. Grando, S.A. Connections of nicotine to cancer. Nat. Rev. Cancer 2014, 14, 419–429. [CrossRef] [PubMed]
12. Sanner, T.; Grimsrud, T.K. Nicotine: Carcinogenicity and effects on response to cancer treatment: A review. Front. Oncol. 2015, 5, 196. [CrossRef] [PubMed]
13. Heeschen, C.; Jang, J.J.; Weis, M.; Pathak, A.; Kaji, S.; Hu, R.S.; Tsao, P.S.; Johnson, F.L.; Cooke, J.P. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 2001, 7, 833–839. [CrossRef] [PubMed]
14. Lee, J.; Cooke, J.P. The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis 2011, 215, 281–283. [CrossRef] [PubMed]
15. Murray, R.P.; Connett, J.E.; Zapawa, L.M. Does nicotine replacement therapy cause cancer? Evidence from the lung health study. Nicotine Tob. Res. 2009, 11, 1076–1082. [CrossRef] [PubMed]
16. Murray, R.P.; Bailey, W.C.; Daniels, K.; Bjornson, W.M.; Kurnow, K.; Connett, J.E.; Nides, M.A.; Kiley, J.P. Safety of nicotine polacrilex gum used by 3094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996, 109, 438–445. [CrossRef] [PubMed]
17. Mills, E.J.; Thorlund, K.; Eapen, S.; Wu, P.; Prochaska, J.J. Cardiovascular events associated with smoking cessation pharmacotherapies: A network meta-analysis. Circulation 2014, 129, 28–41. [CrossRef] [PubMed]
18. Wennmalm, A.; Benthin, G.; Granström, E.F.; Persson, L.; Petersson, L.; Winell, S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 1991, 83, 1698–1704. [CrossRef] [PubMed]
19. Holm, H.; Jarvis, M.J.; Russell, M.A.H.; Feyerabend, C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 1992, 108, 507–511. [CrossRef] [PubMed]
20. Luo, J.; Ye, W.; Zendehdel, K.; Adami, J.; Adami, H.O.; Boffetta, P.; Nyrén, O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study. Lancet 2007, 369, 2015–2020. [CrossRef]
21. Lee, P.N.; Hamling, J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med. 2009, 7, 36. [CrossRef] [PubMed]
22. Huhtasaari, F.; Lundberg, V.; Eliasson, M.; Janlert, U.; Asplund, K. Smokeless tobacco as a possible risk factor for myocardial infarction: A population-based study in middle-aged men. J. Am. Coll. Cardiol. 1999, 34, 1784–1790. [CrossRef]
23. Hansson, J.; Galanti, M.R.; Hergens, M.P.; Fredlund, P.; Ahlbom, A.; Alfredsson, L.; Bellocco, R.; Eriksson, M.; Hallqvist, J.; Hedblad, B.; et al. Use of snus and acute myocardial infarction: Pooled analysis of eight prospective observational studies. Eur. J. Epidemiol. 2012, 27, 771–779. [CrossRef] [PubMed]
24. Hansson, J.; Galanti, M.R.; Hergens, M.P.; Fredlund, P.; Ahlbom, A.; Alfredsson, L.; Bellocco, R.; Engström, G.; Eriksson, M.; Hallqvist, J.; et al. Snus (Swedish smokeless tobacco) use and risk of stroke: Pooled analyses of incidence and survival. J. Int. Med. 2014, 276, 87–95. [CrossRef] [PubMed]
25. Polosa, R.; Rodu, B.; Caponnetto, P.; Maglia, M.; Raciti, C. A fresh look at tobacco harm reduction: The case for the electronic cigarette. Harm. Reduct. J. 2013, 10, 19. [CrossRef] [PubMed]
26. Farsalinos, K.E.; Polosa, R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Ther. Adv. Drug Saf. 2014, 5, 67–86. [CrossRef] [PubMed]
27. Public Health England. E-Cigarettes: An Evidence Update. 2015. PHE Publication Gateway Number: 2015260. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence:update_A_report_commissioned_by_Public_Health_England_FINAL.pdf (accessed on 10 December 2015).
28. Farsalinos, K.E.; Kistler, K.A.; Gillman, G.; Voudris, V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob. Res. 2015, 17, 168–174. [CrossRef] [PubMed]
29. Farsalinos, K.E.; Voudris, V.; Poulas, K. E-cigarettes generate high levels of aldehydes only in “dry puff” conditions. Addiction 2015, 110, 1352–1356. [CrossRef] [PubMed]
30. Goniewicz, M.L.; Knysak, J.; Gawron, M.; Kosmider, L.; Sobczak, A.; Kurek, J.; Prokopowicz, A.; Jablonska-Czapla, M.; Rosik-Dulewska, C.; Havel, C.; et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 2014, 23, 133–139. [CrossRef] [PubMed]
31. Caponnetto, P.; Campagna, D.; Cibella, F.; Morjaria, J.B.; Caruso, M.; Russo, C.; Polosa, R. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS ONE 2013, 8, e66317. [CrossRef] [PubMed]
32. Bullen, C.; Howe, C.; Laugesen, M.; McRobbie, H.; Parag, V.; Williman, J.; Walker, N. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet 2013, 382, 1629–1637. [CrossRef]
33. Adriaens, K.; Van Gucht, D.; Declerck, P.; Baeyens, F. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int. J. Environ. Res. Public Health 2014, 11, 11220–11248. [CrossRef] [PubMed]
34. Brown, J.; Beard, E.; Kotz, D.; Michie, S.; West, R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: A cross-sectional population study. Addiction 2014, 109, 1531–1540. [CrossRef] [PubMed]
35. Lancaster, T.; Stead, L.; Silagy, C.; Sowden, A. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library. BMJ 2000, 321, 355–358. [CrossRef] [PubMed]
36. Rice, V.H.; Hartmann-Boyce, J.; Stead, L.F. Nursing interventions for smoking cessation. Cochrane Database Syst. Rev. 2013, 8. [CrossRef]
37. Patwardhan, S.R.; Murphy, M.A. Survey of GPs’ understanding of tobacco and nicotine products. Drug Alconol Today 2013, 13, 119–150.
38. Overland, S.; Hetland, J.; Aaroe, L.E. Relative harm of snus and cigarettes: What do Norwegian adolescents say? Tob. Control 2008, 17, 422–425. [CrossRef] [PubMed]
39. O’Connor, R.J.; McNeill, A.; Borland, R.; Hammond, D.; King, B.; Boudreau, C.; Cummings, K.M. Smokers’ beliefs about the relative safety of other tobacco products: Findings from the ITC Collaboration. Nicotine Tob. Res. 2007, 9, 1033–1042. [CrossRef] [PubMed]
40. Peiper, N.; Stone, R.; Vanzyl, R.; Rodu, B. University faculty perceptions of the health risk related to cigarettes and smokeless tobacco. Drug Alcohol Rev. 2010, 29, 121–130. [CrossRef] [PubMed]
41. Wikmans, T.; Ramström, L. Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish snus. Tob. Ind. Dis. 2010, 8, 9. [CrossRef] [PubMed]
42. Lund, I.; Scheffels, J. Perceptions of the relative harmfulness of snus among Norwegian general practitioners and their effect on the tendency to recommend snus in smoking cessation. Nicotine Tob. Res. 2012, 14, 169–175. [CrossRef] [PubMed]
43. Dockrell, M.; Morrison, R.; Bauld, L.; McNeill, A. E-cigarettes: Prevalence and attitudes in Great Britain. Nicotine Tob. Res. 2013, 15, 1737–1744. [CrossRef] [PubMed]
44. Adkison, S.E.; O’Connor, R.J.; Bansal-Travers, M.; Hyland, A.; Borland, R.; Yong, H.H.; Cummings, K.M.; McNeill, A.; Thrasher, J.F.; Hammond, D.; et al. Electronic nicotine delivery systems: International tobacco control four-country survey. Am. J. Prev. Med. 2013, 44, 207–215. [CrossRef] [PubMed]
45. Medicines and Healthcare Products Regulatory Agency. Nicotine Replacement Therapy (NRT): New Extended Indication and Consultation, 2010. Available online: http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON065626 (accessed on 20 December 2015).
46. National Institute for Health and Care Excellence. Tobacco-Harm-Reduction Approaches to Smoking: Guidance, 2013. Available online: http://www.nice.org.uk/nicemedia/live/14178/63996/63996.pdf (accessed on 20 December 2015).
47. Food and Drug Administration (FDA). Consumer Health Information. Nicotine Replacement Therapy Labels May Change, April 2013. Available online: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM346012.pdf (accessed on 15 March 2016).
48. Collins, D. Pretesting survey instruments: An overview of cognitive methods. Qual. Life Res. 2003, 12, 229–238. [CrossRef] [PubMed]
49. Farsalinos, K.E.; Romagna, G.; Tsiapras, D.; Kyrzopoulos, S.; Spyrou, A.; Voudris, V. Impact of flavor variability on electronic cigarette use experience: An internet survey. Int. J. Environ. Res. Public Health 2013, 10, 7272–7282. [CrossRef] [PubMed]
50. Farsalinos, K.E.; Romagna, G.; Tsiapras, D.; Kyrzopoulos, S.; Voudris, V. Characteristics, perceived side effects and benefits of electronic cigarette use: A worldwide survey of more than 19,000 consumers. Int. J. Environ. Res. Public Health 2014, 11, 4356–4373. [CrossRef] [PubMed]
51. Farsalinos, K.E.; Romagna, G.; Tsiapras, D.; Kyrzopoulos, S.; Voudris, V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst. Abuse 2013, 7, 139–146. [CrossRef] [PubMed]
52. Farsalinos, K.E.; Voudris, V.; Le Houezec, J. Risks of attempting to regulate nicotine flux in electronic cigarettes. Nicotine Tob. Res. 2015, 17, 163–164. [CrossRef] [PubMed]
53. Farsalinos, K.E.; Stimson, G.V. Is there any legal and scientific basis for classifying electronic cigarettes as medications? Int. J. Drug Policy 2014, 25, 340–345. [CrossRef] [PubMed]
54. Bhatnagar, A.; Whitsel, L.P.; Ribisl, K.M.; Bullen, C.; Chaloupka, F.; Piano, M.R.; Robertson, R.M.; McAuley, T.; Goff, D.; Benowitz, N. Electronic cigarettes: A policy statement from the American Heart Association. Circulation 2014, 130, 1418–1436. [CrossRef] [PubMed]
55. Doll, R.; Hill, A.B. The mortality of doctors in relation to their smoking habits: A preliminary report, 1954. BMJ 2004, 328, 1529–1533. [CrossRef] [PubMed]
56. Gardner, M.N.; Brandt, A.M. The doctors’ choice is America’s choice: The physician in U.S. cigarette advertisements, 1930–1953. Am. J. Public Health 2006, 96, 222–232. [CrossRef] [PubMed]
57. Garfinkel, L. Cigarette smoking among physicians and other health professionals, 1959–1972. CA Cancer J. Clin. 1976, 26, 373–375. [CrossRef] [PubMed]
58. Centers for Disease Control and Prevention (CDC). Smoking Behavior and Attitudes of Physicians, Dentists, Nurses, and Pharmacists, 1975. Available online: http://stacks.cdc.gov/view/cdc/1178/cdc_1178_DS1.pdf (accessed on 20 December 2015).
59. Garfinkel, L.; Stellman, S.D. Cigarette smoking among physicians, dentists, and nurses. CA Cancer J. Clin. 1986, 36, 2–8. [CrossRef] [PubMed]
60. Smith, D.R.; Leggat, P.A. An international review of tobacco smoking in the medical profession: 1974–2004. BMC Public Health 2007, 7, 115. [CrossRef] [PubMed]
61. Stamatopoulou, E.; Stamatiou, K.; Voulioti, S.; Christopoulos, G.; Pantza, E.; Stamatopoulou, A.; Giannopoulos, D. Smoking behavior among nurses in rural Greece. Workplace Health Saf. 2014, 62, 132–134. [CrossRef] [PubMed]
62. Barbouni, A.; Hadjichristodoulou, C.; Merakou, K.; Antoniadou, E.; Kourea, K.; Miloni, E.; Warren, C.W.; Rachiotis, G.; Kremastinou, J. Tobacco use, exposure to secondhand smoke, and cessation counseling among health professions students: Greek data from the global health professions student Survey (GHPSS). Int. J. Environ. Res. Public Health 2012, 9, 331–342. [CrossRef] [PubMed]
63. Kiviniemi, M.T.; Kozlowski, L.T. Deficiencies in public understanding about tobacco harm reduction: Results from a United States national survey. Harm Reduct. J. 2015, 12, 2. [CrossRef] [PubMed]
64. Kozlowski, L.T.; Edwards, B.Q. “Not safe” is not enough: Smokers have a right to know more than there is no safe tobacco product. Tob. Control 2005, 14, ii3–ii7. [CrossRef] [PubMed]
65. Schraufnagel, D.E.; Blasi, F.; Drummond, M.B.; Lam, D.C.; Latif, E.; Rosen, M.J.; Sansores, R.; Van Zyl-Smit, R.; Forum of International Respiratory Societies. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am. J. Respir. Crit Care Med. 2014, 190, 611–618. [CrossRef] [PubMed]
66. Polosa, R.; Campagna, D.; Sands, M.F. Counseling patients with asthma and allergy about electronic cigarettes: An evidence-based approach. Ann. Allergy Asthma Immunol. 2016, 116, 106–111. [CrossRef] [PubMed]
67. Farsalinos, K.; Cibella, F.; Caponnetto, P.; Campagna, D.; Morjaria, J.B.; Battaglia, E.; Caruso, M.; Russo, C.; Polosa, R. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern. Emerg. Med. 2016, 11, 85–94. [CrossRef] [PubMed]
68. Farsalinos, K.E.; Le Houezec, J. Regulation in the face of uncertainty: The evidence on electronic nicotine delivery systems (e-cigarettes). Risk Manag. Healthc. Policy 2015, 8, 157–167. [CrossRef] [PubMed]
69. Etter, J.F. E-cigarettes: Methodological and ideological issues and research priorities. BMC Med. 2015, 13, 32. [CrossRef] [PubMed]
70. McNeill, A.; Etter, J.F.; Farsalinos, K.; Hajek, P.; Le Houezec, J.; McRobbie, H. A critique of aWorld Health Organization-commissioned report and associated paper on electronic cigarettes. Addiction 2014, 109, 2128–2134. [CrossRef] [PubMed]
71. Geller, A.C.; Brooks, D.R.; Powers, C.A.; Brooks, K.R.; Rigotti, N.A.; Bognar, B.; McIntosh, S.; Zapka, J. Tobacco cessation and prevention practices reported by second and fourth year students at U.S. medical schools. J. Gen. Intern. Med. 2008, 23, 1071–1076. [CrossRef] [PubMed]
72. Ferry, L.H.; Grissino, L.M.; Runfola, P.S. Tobacco dependence curricula in U.S. undergraduate medical education. JAMA 1999, 282, 825–829. [CrossRef] [PubMed]
73. Steinberg, M.B.; Giovenco, D.P.; Delnevo, C.D. Patient-physician communication regarding electronic cigarettes. Prev. Med. Rep. 2015, 2, 96–98. [CrossRef] [PubMed]
74. Kandra, K.L.; Ranney, L.M.; Lee, J.G.; Goldstein, A.O. Physicians’ attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013. PLoS ONE 2014, 9, e103462. [CrossRef] [PubMed]
75. Shih, T.-H.; Fan, X. Comparing response rates in email and paper surveys: A meta-analysis. Educ. Res. Rev. 2009, 4, 26–40. [CrossRef]
76. McLeod, C.C.; Klabunde, C.N.; Willis, G.B.; Stark, D. Healthcare provider surveys in the United States, 2000–2010: A review. Eval. Health Prof. 2013, 36, 106–126. [CrossRef] [PubMed]
77. Dykema, J.; Stevenson, J.; Day, B.; Sellers, S.L.; Bonham, V.L. Effects of incentives and prenotification on response rates and costs in a national web survey of physicians. Eval. Health Prof. 2011, 34, 434–447. [CrossRef] [PubMed]
78. Pepper, J.K.; McRee, A.L.; Gilkey, M.B. Healthcare providers’ beliefs and attitudes about electronic cigarettes and preventive counseling for adolescent patients. J. Adolesc. Health 2014, 54, 678–683. [CrossRef] [PubMed]